HC Wainwright & Co. Reiterates Buy on GRI Bio, Maintains $10 Price Target

Benzinga · 2d ago
HC Wainwright & Co. analyst Matthew Keller reiterates GRI Bio (NASDAQ:GRI) with a Buy and maintains $10 price target.